BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cagin YF, Bilgic Y, Berber İ, Yildirim O, Erdogan MA, Firat F, Arslan AK, Colak C, Seckin Y, Harputluoglu M. The risk factors of portal vein thrombosis in patients with liver cirrhosis. Exp Ther Med 2019;17:3189-94. [PMID: 30936992 DOI: 10.3892/etm.2019.7300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Dong G, Huang XQ, Zhu YL, Ding H, Li F, Chen SY. Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis. Ann Transl Med 2021;9:289. [PMID: 33708916 DOI: 10.21037/atm-20-4912] [Reference Citation Analysis]
2 Fortea JI, Carrera IG, Puente Á, Cuadrado A, Huelin P, Tato CÁ, Fernández PÁ, Montes MDRP, Céspedes JN, López AB, Sanchez FJG, Hoyos ML, Crespo J, Fábrega E. Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders. J Clin Med 2020;9:E2822. [PMID: 32878264 DOI: 10.3390/jcm9092822] [Reference Citation Analysis]
3 Zhang Z, Mei Y, Cheng H, Wu X. Portal vein thrombosis secondary to postoperative gastric cancer: Report of two cases. J Int Med Res 2020;48:300060519892417. [PMID: 31840542 DOI: 10.1177/0300060519892417] [Reference Citation Analysis]
4 Zhao J, Li JR, Zhang AJ, Li XL, Liang J, Zheng AP. Relationship between portal vein width and portal vein thrombosis in patients with hepatitis B cirrhosis. Shijie Huaren Xiaohua Zazhi 2022; 30(1): 24-29 [DOI: 10.11569/wcjd.v30.i1.24] [Reference Citation Analysis]
5 Zermatten MG, Fraga M, Calderara DB, Aliotta A, Moradpour D, Alberio L. Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis. JHEP Rep 2020;2:100120. [PMID: 32715285 DOI: 10.1016/j.jhepr.2020.100120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]